Filing Details
- Accession Number:
- 0001493152-20-022869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-03 06:13:35
- Reporting Period:
- 2020-11-30
- Accepted Time:
- 2020-12-03 06:13:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1335105 | Lixte Biotechnology Holdings Inc. | LIXT | Pharmaceutical Preparations (2834) | 202903526 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1369455 | F Philip Palmedo | 248 Route 25A, No. 2 East Setauket, NY 11733 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-30 | 21,053 | $4.75 | 32,056 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common | Warrants to Purchase Common Stock | Acquisiton | 2020-11-30 | 21,053 | $4.75 | 21,053 | $5.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,053 | 2020-11-30 | 2025-11-30 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 183,333 | Indirect | By Philip Palmedo L.P. |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to Purchase Common Stock | $0.72 | 2016-04-25 | 2021-04-25 | 75,000 | 75,000 | Direct |
| Common Stock | Options to Purchase Common Stock | $0.90 | 2017-10-16 | 2022-10-16 | 8,333 | 8,333 | Direct |
| Common Stock | Options to Purchase Common Stock | $6.60 | 2019-05-22 | 2024-05-22 | 8,333 | 8,333 | Direct |
| Common Stock | Warrants to Purchase Common Stock | $6.00 | 2018-12-07 | 2022-12-07 | 16,667 | 16,667 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2021-04-25 | 75,000 | 75,000 | Direct |
| 2022-10-16 | 8,333 | 8,333 | Direct |
| 2024-05-22 | 8,333 | 8,333 | Direct |
| 2022-12-07 | 16,667 | 16,667 | Indirect |
Footnotes
- The reporting person acquired 21,053 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit.
Billionaire Hedge Funds
